Rationale for the design of 3D-printable bioresorbable tissue-engineering chambers to promote the growth of adipose tissue.

Scientific Reports
Pierre FaglinPhilippe Marchetti

Abstract

Tissue engineering chambers (TECs) bring great hope in regenerative medicine as they allow the growth of adipose tissue for soft tissue reconstruction. To date, a wide range of TEC prototypes are available with different conceptions and volumes. Here, we addressed the influence of TEC design on fat flap growth in vivo as well as the possibility of using bioresorbable polymers for optimum TEC conception. In rats, adipose tissue growth is quicker under perforated TEC printed in polylactic acid than non-perforated ones (growth difference 3 to 5 times greater within 90 days). Histological analysis reveals the presence of viable adipocytes under a moderate (less than 15% of the flap volume) fibrous capsule infiltrated with CD68+ inflammatory cells. CD31-positive vascular cells are more abundant at the peripheral zone than in the central part of the fat flap. Cells in the TEC exhibit a specific metabolic profile of functional adipocytes identified by 1H-NMR. Regardless of the percentage of TEC porosity, the presence of a flat base allowed the growth of a larger fat volume (p < 0.05) as evidenced by MRI images. In pigs, bioresorbable TEC in poly[1,4-dioxane-2,5-dione] (polyglycolic acid) PURASORB PGS allows fat flap growth up to 75 00...Continue Reading

References

Mar 7, 2003·Plastic and Reconstructive Surgery·Stefan O P HoferAurora Messina
Dec 7, 2007·The American Journal of Pathology·John A RophaelGeraldine M Mitchell
May 30, 2008·Journal of Lipid Research·Jimin RenCraig R Malloy
Jul 4, 2008·Stem Cells and Development·Guiting LinChing-Shwun Lin
Aug 19, 2009·Molecular and Cellular Endocrinology·V Christiaens, H R Lijnen
May 28, 2011·Plastic and Reconstructive Surgery·Juergen H DoldererKeren M Abberton
Nov 19, 2011·Plastic and Reconstructive Surgery·Michael W FindlayWayne A Morrison
Jul 13, 2013·Tissue Engineering. Part a·Heidi DebelsKeren Abberton
Dec 8, 2015·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Scott A SeamanShayn M Peirce
Feb 20, 2016·Plastic and Reconstructive Surgery. Global Open·Yi YuanRei Ogawa
Jun 16, 2016·Scientific Reports·Mohit P ChhayaJan-Thorsten Schantz
Oct 4, 2016·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Fabian MedvedLaurenz Weitgasser
Jul 14, 2017·Scientific Reports·Myung Chul LeeYong Oock Kim
Aug 31, 2017·Tissue Engineering. Part a·Andreas ArkudasRaymund E Horch
Oct 4, 2017·Journal of Tissue Engineering and Regenerative Medicine·Chen LeiBiao Wang
Mar 27, 2018·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Yoshio TanakaYasuhiko Tabata
Jun 26, 2018·Trends in Biotechnology·Kiryu K YapGeraldine M Mitchell
Oct 17, 2018·Plastic and Reconstructive Surgery. Global Open·Akimitsu NishibayashiKo Hosokawa

❮ Previous
Next ❯

Citations

May 22, 2021·Trends in Biotechnology·Gretel S MajorKhoon S Lim

❮ Previous
Next ❯

Methods Mentioned

BETA
differential scanning calorimetry
SMA
NMR
imaging techniques
dissection
sedation
electrophoresis

Software Mentioned

Graphpad Prism
Blender
Pixmeo©
Zen
OsiriX
ITK
ImageJ
SNAP

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2021 Meta ULC. All rights reserved